NASDAQ:GRCE | Operating Income | Grace Therapeutics, Inc.

Complete source-backed operating income history.

Available history
2019-03-31 to 2026-06-30
Data captured

Historical Operating Income

DateOperating Income
2026-06-30-$15.92M
2026-03-31-$3.01M
2025-12-31-$2.45M
2025-09-30-$2.53M
2025-06-30-$3.09M
2025-03-31-$3.18M
2024-12-31-$3.7M
2024-09-30-$4.83M
2024-06-30-$4.96M
2024-03-31-$3.26M
2023-12-31-$3.04M
2023-09-30-$2.09M
2023-06-30-$4.45M
2023-03-31-$38.07M
2022-12-31-$4.25M
2022-09-30-$5.11M
2022-06-30-$4.73M
2022-03-31-$4.4M
2021-12-31-$4.47M
2021-09-30-$3.57M
2021-06-30-$3.15M
2021-03-31-$2.3M
2020-12-31-$1.96M
2020-09-30-$8.03M
2020-06-30-$4.12M
2020-03-31-$4.03M
2019-12-31-$6.15M
2019-09-30-$6.26M
2019-06-30-$8.01M

Annual Operating Income

DateOperating Income
2026-03-31-$11.08M
2025-03-31-$16.68M
2024-03-31-$12.85M
2023-03-31-$52.16M
2022-03-31-$15.59M
2021-03-31-$16.42M
2020-03-31-$24.44M
2019-03-31-$34.41M